Literature DB >> 11980858

Pseudomonas aeruginosa exotoxin A and keratitis in mice.

Christopher M Pillar1, Jeffery A Hobden.   

Abstract

PURPOSE: To determine the importance of Pseudomonas aeruginosa exotoxin A (ETA) as a virulence factor in corneal disease.
METHODS: Isogenic mutants deficient in ETA were constructed in P. aeruginosa strains PAO1 and ATCC 19660 by allelic exchange and then evaluated for virulence in a mouse model of bacterial keratitis. The effect of ETA on adherence to scarified corneal epithelium was assessed in an in vitro organ culture model.
RESULTS: Mutants of either P. aeruginosa PAO1 or 19660, deficient in ETA, adhered to wounded corneal tissue and initiated ocular disease similar to that in wild-type strains. However, in contrast to wild-type strains, ETA mutants were quickly cleared from the eye, inflammation diminished, and the cornea healed.
CONCLUSIONS: Although ETA has no effect on the ability of P. aeruginosa to adhere to corneal wounds or to initiate Pseudomonas keratitis, it is crucial for the organism to persist in the eye and ultimately cause disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980858

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.925


  14 in total

Review 1.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

2.  Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers.

Authors:  Analette I Lopez; Rose Y Reins; Alison M McDermott; Barbara W Trautner; Chengzhi Cai
Journal:  Mol Biosyst       Date:  2009-07-03

Review 3.  Peptide therapeutics for treating ocular surface infections.

Authors:  Curtis R Brandt
Journal:  J Ocul Pharmacol Ther       Date:  2014-09-24       Impact factor: 2.671

4.  VIP and growth factors in the infected cornea.

Authors:  Xiaoyu Jiang; Sharon A McClellan; Ronald P Barrett; Elizabeth A Berger; Yunfan Zhang; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-03       Impact factor: 4.799

5.  In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.

Authors:  Ling C Huang; Rachel L Redfern; Srihari Narayanan; Rose Y Reins; Alison M McDermott
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

6.  Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections.

Authors:  Eric C Ledbetter; James J Mun; David Kowbel; Suzanne M J Fleiszig
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

7.  Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups.

Authors:  Michelle K Calabretta; Amit Kumar; Alison M McDermott; Chengzhi Cai
Journal:  Biomacromolecules       Date:  2007-05-19       Impact factor: 6.988

Review 8.  Contact lens-related corneal infection: Intrinsic resistance and its compromise.

Authors:  Suzanne M J Fleiszig; Abby R Kroken; Vincent Nieto; Melinda R Grosser; Stephanie J Wan; Matteo M E Metruccio; David J Evans
Journal:  Prog Retin Eye Res       Date:  2019-11-20       Impact factor: 21.198

9.  A dominant-negative approach that prevents diphthamide formation confers resistance to Pseudomonas exotoxin A and diphtheria toxin.

Authors:  Vincent Roy; Karim Ghani; Manuel Caruso
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.752

Review 10.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.